Top Biotechnology companies in Singapore by Debt to Equity Ratio
This ranking features the top 3 Biotechnology companies in Singapore ranked by Debt to Equity Ratio, averaging a Debt to Equity Ratio of 0.31, for February 08, 2025.
Singapore
Biotechnology
Debt to Equity Ratio
Frequently Asked Questions
-
Which Biotechnology company in Singapore has the highest Debt to Equity Ratio ?
The Biotechnology company in Singapore with the highest Debt to Equity Ratio is Wave Life Sciences Ltd. (NasdaqGM: WVE) at 0.68.
-
Which Biotechnology company in Singapore has the lowest Debt to Equity Ratio ?
The Biotechnology company in Singapore with the lowest Debt to Equity Ratio is CytoMed Therapeutics Limited (NasdaqCM: GDTC) at 0.05.
-
What are the top 10 Biotechnology companies in Singapore by Debt to Equity Ratio ?
The top 10 Biotechnology companies in Singapore by Debt to Equity Ratio are Wave Life Sciences Ltd., Prestige BioPharma Limited and CytoMed Therapeutics Limited.
-
What are the bottom 10 Biotechnology companies in Singapore by Debt to Equity Ratio ?
The bottom 10 Biotechnology companies in Singapore by Debt to Equity Ratio are CytoMed Therapeutics Limited, Prestige BioPharma Limited and Wave Life Sciences Ltd..
